| Lupin gets USFDA nod for Cefdinir suspension |
| Our Web Bureau / Mumbai June 02, 2006 |
| The US Food and Drug Administration (USFDA) has approved Lupin's abbreviated new drug application (ANDA) for Cefdinir suspension 125mg/5ml. According to an official release issued to the BSE today, Cefdinir is a third generation cephalosporin administered orally to treat a wide variety of bacterial infections. "The approval of our Cefdinir suspension and the recent approval for the capsule form by FDA reinforces Lupin |
